Skip to main content

Enable your glycan workflows with glycobiology enzymes

AdvanceBio glycoenzymes, including highly purified exoglycosidases and endoglycosidases, enable your glycan workflows. When combined, glycobiology enzymes can be utilized in released N-glycan assays, protein modification assays, and sequencing studies. Enzymes in the portfolio include PNGase F (N-glycanase), PNGase A, Sialidase A, Sialidase C, Sialidase S, Sialidase V, N-acetylhexosaminidase, α-galactosidase, ß-galactosidase and α-mannosidase.

Glycobiology Enzymes for N-Glycan Workflows

All Categories

Featured Tools

Bio HPLC Columns eSelector Tools

Intuitive process to help you select the right chromatography column for your biopharmaceutical applications.

Preparative HPLC Scaling Calculator

Scale between analytical and prep methods; calculate column capacity, # of injections, run time & mobile phase use.

Oligonucleotide Virtual Lab

Explore proven methods and resources to help advance analysis for the broad range of oligonucleotide workflows.

Featured Literature

N-Glycan Analysis: Better Together

Push your Glycoprotein analysis to new levels of performance.

Glycan Standard Structures

Catalog of glycan standards and libraries, complete with quick links to easily get more details for each online.

Agilent Biocolumns - Critical Quality Attributes - Application Compendium

Critical Quality Attributes application compendium

Featured Videos
Return to top
Featured News

Agilent Wins Multiple 2022 Scientists' Choice Awards

Agilent received two 2022 Scientists’ Choice Awards for Drug Discovery & Development, Virtual Event of the Year and Innovative Content of the Year, at the SLAS2022 International Conference & Exhibition on February 7th, 2022. The Scientists’ Choice Awards recognize the world’s most innovative and effective analytical science technologies and communications.

The Importance of Glycan Analysis and Characterization for Biopharma

Professor Michael Butler, head of the National Institute for Bioprocessing Research and Training (NIBRT) Cell Technology Group (CTG), explains that the characterisation and analysis of glycans is important for the biopharma sector as it can help in the development of therapeutic agents, such as monoclonal antibodies and other recombinant proteins. These are used in therapies in a range of serious conditions including cancer, inflammatory diseases, and cardiovascular diseases. The mechanism of action depends upon their strong affinity to molecular targets associated with disease.

0 product selected.

Clear All